VIA
EVMN

Virtus Investment Advisers’s Evommune Inc EVMN Stock Holding History

Virtus Investment Advisers’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219K Buy
+16,500
New +$383K 0.05% 375

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Virtus Investment Advisers's EVMN Position: Q2 2026 in Review

Virtus Investment Advisers opened a new position in Evommune Inc (EVMN) in Q2 2026: 16,500 shares worth $219K. The stake represents 0.05% of the portfolio and ranks #375 among its holdings.

105 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • Virtus Investment Advisers held 16,500 shares of Evommune Inc worth $219K as of Q2 2026.
  • Evommune Inc was a new Virtus Investment Advisers position in Q2 2026.
  • Evommune Inc made up 0.05% of Virtus Investment Advisers's portfolio in Q2 2026, its #375 holding.
  • 105 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.